In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing immune cells that could make “off-the-shelf” cancer medications more potent ...
We are focused on targeting tumor recurrence by developing therapies that enable the immune system to build up active immunity against residual cancer cells. Active immunity is the only long-lasting ...
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
The collaboration will leverage Graph's lab-in-the-loop platform with Parse's GigaLab to profile hundreds of millions of cells from patients with immune diseases under systematic perturbation, making ...
Trillions of microorganisms live in the human gut, collectively forming the gut microbiome. They support important bodily ...
CAMBRIDGE, Mass., May 7, 2026 /PRNewswire/ -- Repertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell-targeted immune medicines, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results